SWKHL
Get informed when a big investor buys or sells
+ FollowUndervalued by 7.1% based on the discounted cash flow analysis.
| Market cap | $305.42 Million |
|---|---|
| Enterprise Value | $294.77 Million |
| Dividend Yield | $2.25 (-) |
| Earnings per Share | $-0.21 |
| Beta | 0.06 |
| Outstanding Shares | 12,162,000 |
| P/E Ratio | -76.34 |
|---|---|
| PEG | 17.75 |
| Price to Sales | 8.4 |
| Price to Book Ratio | 1.33 |
| Enterprise Value to Revenue | 7.23 |
| Enterprise Value to EBIT | 11.83 |
| Enterprise Value to Net Income | -117 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.14 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...